446 related articles for article (PubMed ID: 27493155)
1. The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
Gueye AB; Pryslawsky Y; Trigo JM; Poulia N; Delis F; Antoniou K; Loureiro M; Laviolette SR; Vemuri K; Makriyannis A; Le Foll B
Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27493155
[TBL] [Abstract][Full Text] [Related]
2. Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
Schindler CW; Redhi GH; Vemuri K; Makriyannis A; Le Foll B; Bergman J; Goldberg SR; Justinova Z
Neuropsychopharmacology; 2016 Aug; 41(9):2283-93. PubMed ID: 26888056
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid CB
He XH; Jordan CJ; Vemuri K; Bi GH; Zhan J; Gardner EL; Makriyannis A; Wang YL; Xi ZX
Acta Pharmacol Sin; 2019 Mar; 40(3):365-373. PubMed ID: 29967454
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B
Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.
Järbe TU; LeMay BJ; Olszewska T; Vemuri VK; Wood JT; Makriyannis A
Pharmacol Biochem Behav; 2008 Nov; 91(1):84-90. PubMed ID: 18640150
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
Forget B; Guranda M; Gamaleddin I; Goldberg SR; Le Foll B
Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774
[TBL] [Abstract][Full Text] [Related]
7. Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).
Cohen C; Perrault G; Griebel G; Soubrié P
Neuropsychopharmacology; 2005 Jan; 30(1):145-55. PubMed ID: 15292905
[TBL] [Abstract][Full Text] [Related]
8. Contextual renewal of nicotine seeking in rats and its suppression by the cannabinoid-1 receptor antagonist Rimonabant (SR141716A).
Diergaarde L; de Vries W; Raasø H; Schoffelmeer AN; De Vries TJ
Neuropharmacology; 2008 Oct; 55(5):712-6. PubMed ID: 18588903
[TBL] [Abstract][Full Text] [Related]
9. Nicotine reinforcement is reduced by cannabinoid CB1 receptor blockade in the ventral tegmental area.
Simonnet A; Cador M; Caille S
Addict Biol; 2013 Nov; 18(6):930-6. PubMed ID: 22784230
[TBL] [Abstract][Full Text] [Related]
10. The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats.
Sink KS; McLaughlin PJ; Wood JA; Brown C; Fan P; Vemuri VK; Peng Y; Olszewska T; Thakur GA; Makriyannis A; Parker LA; Salamone JD
Neuropsychopharmacology; 2008 Mar; 33(4):946-55. PubMed ID: 17581535
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid-1 receptor neutral antagonist reduces binge-like alcohol consumption and alcohol-induced accumbal dopaminergic signaling.
Balla A; Dong B; Shilpa BM; Vemuri K; Makriyannis A; Pandey SC; Sershen H; Suckow RF; Vinod KY
Neuropharmacology; 2018 Mar; 131():200-208. PubMed ID: 29109060
[TBL] [Abstract][Full Text] [Related]
12. Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142.
Sink KS; Segovia KN; Sink J; Randall PA; Collins LE; Correa M; Markus EJ; Vemuri VK; Makriyannis A; Salamone JD
Eur Neuropsychopharmacol; 2010 Feb; 20(2):112-22. PubMed ID: 20015619
[TBL] [Abstract][Full Text] [Related]
13. The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats.
Sink KS; Segovia KN; Collins LE; Markus EJ; Vemuri VK; Makriyannis A; Salamone JD
Pharmacol Biochem Behav; 2010 Jun; 95(4):479-84. PubMed ID: 20347865
[TBL] [Abstract][Full Text] [Related]
14. The CB1 antagonist rimonabant (SR141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse.
Ward SJ; Rosenberg M; Dykstra LA; Walker EA
Drug Alcohol Depend; 2009 Dec; 105(3):248-55. PubMed ID: 19679410
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration--comparison with CB(1) receptor blockade.
Forget B; Coen KM; Le Foll B
Psychopharmacology (Berl); 2009 Sep; 205(4):613-24. PubMed ID: 19484221
[TBL] [Abstract][Full Text] [Related]
16. The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats.
Shoaib M
Neuropharmacology; 2008 Feb; 54(2):438-44. PubMed ID: 18054052
[TBL] [Abstract][Full Text] [Related]
17. CB1 receptor antagonist AM4113 reverts the effects of cannabidiol on cue and stress-induced reinstatement of cocaine-seeking behaviour in mice.
Luján MÁ; Alegre-Zurano L; Martín-Sánchez A; Cantacorps L; Valverde O
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Mar; 113():110462. PubMed ID: 34688811
[TBL] [Abstract][Full Text] [Related]
18. SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats.
de Bruin NM; Lange JH; Kruse CG; Herremans AH; Schoffelmeer AN; van Drimmelen M; De Vries TJ
Behav Brain Res; 2011 Mar; 217(2):408-15. PubMed ID: 21074574
[TBL] [Abstract][Full Text] [Related]
19. The novel MAGL inhibitor MJN110 enhances responding to reward-predictive incentive cues by activation of CB1 receptors.
Feja M; Leigh MPK; Baindur AN; McGraw JJ; Wakabayashi KT; Cravatt BF; Bass CE
Neuropharmacology; 2020 Jan; 162():107814. PubMed ID: 31628934
[TBL] [Abstract][Full Text] [Related]
20. Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251.
Nawata Y; Kitaichi K; Yamamoto T
Drug Alcohol Depend; 2016 Mar; 160():76-81. PubMed ID: 26796595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
